Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes (Q70474464)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

A Kalinkovich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

G Livshits

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

H Engelmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

N Harpaz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

R Burstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

M Kaminsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

D Wallach

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

Z Bentwich

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

350-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

Tumor necrosis factor-alpha in advanced HIV infection in the absence of AIDS-related secondary infections

11 October 2019

cites work

1 reference

12 December 2020

Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases

1 reference

12 December 2020

The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value

1 reference

12 December 2020

Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.

1 reference

12 December 2020

Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis

1 reference

12 December 2020

Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity

1 reference

12 December 2020

Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome

1 reference

12 December 2020

Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor

1 reference

12 December 2020

A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

1 reference

12 December 2020

Neopterin as a marker for activated cell-mediated immunity: application in HIV infection

1 reference

12 December 2020

Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors

1 reference

12 December 2020

Infection with HIV is associated with elevated IL-6 levels and production

1 reference

12 December 2020

Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection

1 reference

12 December 2020

Serum level of TNF alpha in HIV-infected individuals

1 reference

12 December 2020

Shedding of tumor necrosis factor receptors by activated human neutrophils

1 reference

12 December 2020

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients

1 reference

12 December 2020

Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement

1 reference

12 December 2020

A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF.

1 reference

12 December 2020

Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection

1 reference

12 December 2020

Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children

1 reference

12 December 2020

Immune activation markers and AIDS prognosis

1 reference

12 December 2020

Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion

1 reference

12 December 2020

Soluble cytokine receptors: their role in immunoregulation

1 reference

12 December 2020

Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease

1 reference

12 December 2020

Shedding of the soluble form of the CD8 complex by CD8 +/HLA-DR + cells in HIV-1-infected patients

1 reference

12 December 2020

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

1 reference

12 December 2020

Tumor necrosis factor: receptors and inhibitors

1 reference

12 December 2020

Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients

1 reference

12 December 2020

Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils

1 reference

12 December 2020

Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality

1 reference

12 December 2020

Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection

1 reference

12 December 2020

Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-α and immunoglobulin G and A concentrations in children with HIV infection

1 reference

12 December 2020

Soluble IL-2 receptor and tumour necrosis factor-alpha in plasma of haemophilia patients infected with HIV.

1 reference

12 December 2020

Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?

1 reference

12 December 2020

Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome

1 reference

12 December 2020

The Walter Reed staging classification for HTLV-III/LAV infection.

1 reference

12 December 2020

Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Heterogeneity of insulin and insulin-like growth factor I binding in a human Burkitt type ALL cell line during the cell cycle and in three Burkitt type ALL sublines

1 reference

12 December 2020

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders.

1 reference

12 December 2020

Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations

1 reference

12 December 2020

Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1

1 reference

12 December 2020

Isolation and characterization of a tumor necrosis factor binding protein from urine

1 reference

12 December 2020

Soluble CD8 during T cell activation

1 reference

12 December 2020

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

12 December 2020

Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens

1 reference

12 December 2020

Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection

1 reference

12 December 2020

Induction of soluble tumour necrosis factor receptors during treatment with interleukin-2.

1 reference

12 December 2020

10.1111/J.1365-2249.1993.TB08184.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8396513%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference